mrsmuckers Overview I previously covered Aflac (NYSE:AFL) back in early April, and since then, the performance has been stellar. AFL has provided a total return greater than 27% since my last issued buy rating, outpacing the S&P 500. I strongly believe that AFL will still benefit from a growing amount of cancer cases globally and long-term shareholders will be handsomely rewarded. However, I wanted to reassess and cover the financial strength of AFL and how it has helped the company navigate through all hea ...